Axiom Investors LLC DE Cuts Position in Celestica, Inc. $CLS

Axiom Investors LLC DE lessened its stake in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS by 28.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 66,713 shares of the technology company's stock after selling 26,031 shares during the quarter. Axiom Investors LLC DE owned 0.06% of Celestica worth $19,721,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. increased its holdings in Celestica by 5,806,149.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company's stock valued at $1,081,323,000 after acquiring an additional 3,657,874 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Celestica by 471.5% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 3,146,928 shares of the technology company's stock valued at $775,133,000 after acquiring an additional 2,596,318 shares in the last quarter. Viking Global Investors LP purchased a new position in Celestica during the 3rd quarter valued at about $424,459,000. Norges Bank purchased a new position in Celestica during the 4th quarter valued at about $456,511,000. Finally, JPMorgan Chase & Co. increased its holdings in Celestica by 24.8% during the 4th quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company's stock valued at $1,187,650,000 after acquiring an additional 798,782 shares in the last quarter. Hedge funds and other institutional investors own 67.38% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on CLS shares. Susquehanna raised their price target on shares of Celestica from $460.00 to $510.00 and gave the stock a "positive" rating in a research note on Wednesday, April 29th. Rothschild & Co Redburn started coverage on shares of Celestica in a research note on Friday, May 1st. They set a "buy" rating and a $460.00 price target on the stock. Wolfe Research raised shares of Celestica to a "strong-buy" rating in a research note on Tuesday, February 17th. Royal Bank Of Canada raised their price target on shares of Celestica from $400.00 to $440.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 29th. Finally, UBS Group raised their price target on shares of Celestica from $355.00 to $400.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $427.42.

Insiders Place Their Bets

In other Celestica news, Director Michael Max Wilson sold 4,168 shares of the business's stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the completion of the sale, the director owned 24,718 shares in the company, valued at $8,238,756.58. The trade was a 14.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 1.10% of the stock is currently owned by insiders.

Celestica Trading Down 4.0%

Shares of CLS stock opened at $370.97 on Wednesday. The stock has a market cap of $42.65 billion, a price-to-earnings ratio of 44.86, a price-to-earnings-growth ratio of 0.90 and a beta of 2.02. The company has a quick ratio of 0.73, a current ratio of 1.26 and a debt-to-equity ratio of 0.36. Celestica, Inc. has a fifty-two week low of $117.28 and a fifty-two week high of $474.02. The firm's 50 day moving average price is $368.88 and its two-hundred day moving average price is $322.85.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its earnings results on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $2.08 by $0.08. The business had revenue of $3.96 billion for the quarter, compared to analysts' expectations of $3.97 billion. Celestica had a net margin of 6.95% and a return on equity of 36.91%. The business's revenue for the quarter was up 52.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.20 earnings per share. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. On average, analysts anticipate that Celestica, Inc. will post 9.5 EPS for the current year.

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.